Close

Alnylam Pharmaceuticals (ALNY) PT Raised to $135 at Bernstein

September 21, 2017 7:23 AM EDT Send to a Friend
Bernstein raised its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $135.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login